Goldman Sachs’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
166,087
+65,713
| +65% | +$145K | ﹤0.01% | 4427 |
|
|
2025
Q1 | $217K | Sell |
100,374
-10,903
| -10% | -$23.6K | ﹤0.01% | 4646 |
|
|
2024
Q4 | $471K | Buy |
111,277
+65,740
| +144% | +$278K | ﹤0.01% | 4326 |
|
|
2024
Q3 | $521K | Buy |
45,537
+31,382
| +222% | +$359K | ﹤0.01% | 4094 |
|
|
2024
Q2 | $151K | Buy |
+14,155
| New | +$151K | ﹤0.01% | 4430 |
|